Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 25 , ISSUE 5 ( May, 2021 ) > List of Articles

LETTER TO EDITOR

Pathogenetic Mechanism of Procalcitonin in COVID-19

Franz J. Wiedermann

Citation Information : Wiedermann FJ. Pathogenetic Mechanism of Procalcitonin in COVID-19. Indian J Crit Care Med 2021; 25 (5):594-594.

DOI: 10.5005/jp-journals-10071-23812

License: CC BY-NC 4.0

Published Online: 01-05-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract
HTML PDF Share
  1. Savio RD. Procalcitonin (in COVID-19): the incessant quest. Indican J Crit Care Med 2021;25(1):1–2. DOI: 10.5005/jp-journals-10071-23698.
  2. Wiedermann FJ, Kaneider N, Egger P, Tiefenthaler W, Wiedermann CJ, Lindner KH, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002;30(5):1112–1117. DOI: 10.1097/00003246-200205000-00025. PMID: 12006810.
  3. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum rective to procalcitonin in experimetnal sepsis. Crit Care Med 1998;26(6):1001–1006. DOI: 10.1097/00003246-199806000-00015. PMID: 9635646.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.